DK1334117T3 - Antibakterielle midler omfattende konjugater af glycopeptider og peptidiske membran-associerende elementer - Google Patents

Antibakterielle midler omfattende konjugater af glycopeptider og peptidiske membran-associerende elementer

Info

Publication number
DK1334117T3
DK1334117T3 DK01980689.2T DK01980689T DK1334117T3 DK 1334117 T3 DK1334117 T3 DK 1334117T3 DK 01980689 T DK01980689 T DK 01980689T DK 1334117 T3 DK1334117 T3 DK 1334117T3
Authority
DK
Denmark
Prior art keywords
agents
membrane
glycopeptides
conjugates
antibacterial agents
Prior art date
Application number
DK01980689.2T
Other languages
English (en)
Inventor
Matthew Allister Cooper
Jason Richard Emmbrook Betley
Original Assignee
Cambridge Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Entpr Ltd filed Critical Cambridge Entpr Ltd
Application granted granted Critical
Publication of DK1334117T3 publication Critical patent/DK1334117T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK01980689.2T 2000-11-03 2001-11-02 Antibakterielle midler omfattende konjugater af glycopeptider og peptidiske membran-associerende elementer DK1334117T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0026924.1A GB0026924D0 (en) 2000-11-03 2000-11-03 Antibacterial agents
PCT/GB2001/004867 WO2002036612A1 (en) 2000-11-03 2001-11-02 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements

Publications (1)

Publication Number Publication Date
DK1334117T3 true DK1334117T3 (da) 2012-05-29

Family

ID=9902519

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01980689.2T DK1334117T3 (da) 2000-11-03 2001-11-02 Antibakterielle midler omfattende konjugater af glycopeptider og peptidiske membran-associerende elementer

Country Status (10)

Country Link
US (1) US7078380B2 (da)
EP (1) EP1334117B1 (da)
JP (1) JP4209673B2 (da)
AT (1) ATE543831T1 (da)
AU (2) AU2002212482B2 (da)
CA (1) CA2426012C (da)
DK (1) DK1334117T3 (da)
ES (1) ES2381649T3 (da)
GB (1) GB0026924D0 (da)
WO (1) WO2002036612A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0220936D0 (en) 2002-09-05 2002-10-23 Adprotech Ltd Modified therapeutic agents
CN100506841C (zh) * 2003-05-01 2009-07-01 科内尔研究基金会 将分子递送到细胞的方法和载体复合物
JP4524671B2 (ja) * 2003-10-29 2010-08-18 東亞合成株式会社 抗菌ペプチド及びその利用
US20060105941A1 (en) * 2004-11-12 2006-05-18 Allergan, Inc. Mixed antibiotic codrugs
AU2006225382B2 (en) * 2005-03-21 2013-05-09 Cytacoat Ab An antimicrobial agent comprising a cysteine compound covalently bound to a substrate, in particular by binding through an S-S bridge via a spacer molecule
JP2009526046A (ja) 2006-02-10 2009-07-16 デルマゲン アクティエボラーグ 新規分子
JP2009529530A (ja) * 2006-03-09 2009-08-20 インフラザイム・ファーマシューティカルズ・リミテッド 新規の抗生物質組成物
JP5158716B2 (ja) * 2006-08-24 2013-03-06 国立大学法人群馬大学 乳酸残基を含有するデプシペプチド
US20090246250A1 (en) * 2008-03-27 2009-10-01 Affinergy Coating compositions having improved performance
US8404636B2 (en) 2008-07-17 2013-03-26 George Mason Intellectual Properties, Inc. Targeted delivery of antimicrobial agents
EP3384938A1 (en) 2011-09-12 2018-10-10 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
AU2013243949A1 (en) 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of biologics and proteins associated with human disease
EP2833923A4 (en) 2012-04-02 2016-02-24 Moderna Therapeutics Inc MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
CN104418941B (zh) * 2013-08-19 2017-11-07 爱斯医药科技(南京)有限公司 万古霉素衍生物、制备方法及其应用
GB201402267D0 (en) * 2014-02-10 2014-03-26 Cambridge Entpr Ltd Antibacterial agents
WO2015164666A1 (en) * 2014-04-23 2015-10-29 Avrygen Corporation Nanoparticles for targeted gene therapy and methods of use thereof
GB201415776D0 (en) * 2014-09-05 2014-10-22 Singh Ishwar And Taylor Edward New antibacterial products
WO2016191658A1 (en) * 2015-05-28 2016-12-01 President And Fellows Of Harvard College Inhibitors of bacterial glycosyl transferases
KR20180101341A (ko) 2015-11-10 2018-09-12 비스테라, 인크. 리포폴리사카라이드에 특이적으로 결합하는 항체 분자-약물 접합체 및 그의 용도
US11084833B2 (en) 2016-10-10 2021-08-10 The Johns Hopkins University Antibacterial agents against D,D- and L,D-transpeptidases
EP3571223B1 (en) 2017-01-18 2024-09-18 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
CN110240656A (zh) * 2019-04-24 2019-09-17 中山大学附属第三医院 一种融合蛋白及其制备方法与应用
JP2023521319A (ja) 2020-04-03 2023-05-24 ビステラ， インコーポレイテッド 抗体分子－薬物コンジュゲートおよびその使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067099A (en) * 1955-09-16 1962-12-04 Lilly Co Eli Vancomycin and method for its preparation
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5834430A (en) * 1995-05-31 1998-11-10 Biosynth S.R.L. Potentiation of antibiotics
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
GB9614871D0 (en) 1996-07-15 1996-09-04 Smithkline Beecham Plc Compounds
AU734827B2 (en) 1997-05-21 2001-06-21 Board Of Trustees Of The Leland Stanford Junior University Composition and method for enhancing transport across biological membranes
EP1212094A2 (en) * 1999-04-23 2002-06-12 St. Jude Medical, Inc. Delivery of antimicrobial toxins
US20040072743A1 (en) 2000-04-06 2004-04-15 Christensen Jeppe Viggo Pharmaceutical composition of modified pna molecules

Also Published As

Publication number Publication date
ATE543831T1 (de) 2012-02-15
JP2004513132A (ja) 2004-04-30
AU1248202A (en) 2002-05-15
WO2002036612A1 (en) 2002-05-10
US7078380B2 (en) 2006-07-18
AU2002212482B2 (en) 2006-09-21
ES2381649T3 (es) 2012-05-30
US20040106544A1 (en) 2004-06-03
GB0026924D0 (en) 2000-12-20
EP1334117A1 (en) 2003-08-13
JP4209673B2 (ja) 2009-01-14
CA2426012A1 (en) 2002-05-10
CA2426012C (en) 2013-06-11
EP1334117B1 (en) 2012-02-01

Similar Documents

Publication Publication Date Title
DK1334117T3 (da) Antibakterielle midler omfattende konjugater af glycopeptider og peptidiske membran-associerende elementer
CY1108437T1 (el) Φαρμακοτεχνικες μορφες οι οποιες περιεχουν μια ενωση κεφαλοσπορινης και η χρηση τους στη θεραπεια βακτηριακων λοιμωξεων σε γατους και σκυλους
BR9609281A (pt) Método para o controle de bactérias gram-positivas resistentes a antibióticos e tratamento de infecções
NO2011025I1 (no) Telavancin, eller et farmasøytisk aksseptabelt salt derav, herunder inkludert telavancin hydroklorid
PE20001112A1 (es) Derivados de quinolina como agentes antibacterianos
MXPA05009352A (es) Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas.
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
ES2162796T3 (es) Proteinas biocidas.
TR200003170T2 (tr) MRS inhibitörleri ve bakterisid olarak kullanılan quinolone'lar
PT1077718E (pt) Melhoramentos da actividade de agentes antibacterianos de oxazolidinona por derivados de arginina
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ES2191061T3 (es) Antibioticos sinteticos.
ATE279519T1 (de) Antimikrobielle proteine
DK1309336T3 (da) Laspartomycin-derivater og fremstilling og anvendelse deraf
ATE449775T1 (de) Carbacephem beta-lactam-antibiotika
HUP0000146A2 (hu) Eljárás Streptococcus pneumoniae-fertőzés kezelésére
DE60115851D1 (de) Anti-infektionsmittel, die gegen gegenüber mehreren arzneimitteln resistente bakterienstämme nützlich sind
CY1113157T1 (el) Αντιβιοτικο 107891, παραγοντες του, φαρμακευτικως αποδεκτα αλατα και συνθεσεις και η χρηση τους
ATE273319T1 (de) Antimikrobielle pseudopeptide
EA200501830A1 (ru) Новые производные линкомицина, обладающие антимикробной активностью
ES2158770B1 (es) Nuevos glicopeptidos.